SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001564590-20-032360
Filing Date
2020-07-14
Accepted
2020-07-14 16:59:10
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 abio-424b5.htm 424B5 740597
2 GRAPHIC gstqfzhvk03h000003.jpg GRAPHIC 3017
3 GRAPHIC gstqfzhvk03h000005.jpg GRAPHIC 3073
4 GRAPHIC gstqfzhvk03h000002.jpg GRAPHIC 3871
5 GRAPHIC gstqfzhvk03h000001.jpg GRAPHIC 2922
6 GRAPHIC gstqfzhvk03h000004.jpg GRAPHIC 2922
  Complete submission text file 0001564590-20-032360.txt   764335
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-238067 | Film No.: 201027574
SIC: 2835 In Vitro & In Vivo Diagnostic Substances